foxo4-dri senolytic or senomorphic

foxo4-dri senolytic or senomorphic Targeting cellular senescence with senotherapeutics: senolytics and senomorphics - Zhang - 2023 - The FEBS Journal Senolytics: charting a new course

Name: foxo4-dri senolytic or senomorphic Targeting cellular senescence with senotherapeutics: senolytics and senomorphics - Zhang - 2023 - The FEBS Journal Senolytics: charting a new course
Brand: centoria.fr
SKU: 87954946064
Price: 21.50 USD
Availability: InStock
Rating: 4.0819 (26 reviews)

Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect

SKU: 87954946064 · From centoria.fr

4.1

USD21.50 USD42.50

Pay in 4 interest-free payments of $5.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

In this study, we hypothesized that FOXO4-DRI treatment could remove the senescent cells in the expanded chondrocytes, thus enhancing their potential in generating high-quality cartilage